Introduction {#s1}
============

Enterohemorrhagic Escherichia coli (EHEC) and enteropathogenic *E. coli* (EPEC) are important diarrheagenic pathotypes responsible for substantial human morbidity and mortality \[[@B1]\]. Both carry a chromosomally-located island known as the locus of enterocyte effacement (LEE) that produces essential effector molecules required for the formation of characteristic attaching and effacing lesions on gastrointestinal epithelial cells \[[@B2]\]. EHEC are a subset of Shiga toxin-producing *E. coli* (STEC) expressing phage-derived Shiga toxins and accessory virulence factors, including intimin (Eae) and the plasmid-encoded enterohemolysin EhxA, responsible for the development of serious post-infection sequelae, such as haemorrhagic colitis and haemolytic uremic syndrome (HUS) \[[@B3]\]. Although most EHEC infections cause self-limiting bloody diarrhoea, in 5 to 7% of cases patients develop HUS, the leading cause of acute renal failure in children \[[@B4]\].

Ruminants are a key reservoir for both EHEC and atypical EPEC (aEPEC), an emerging cause of diarrhoea in both humans and animals globally \[[@B5],[@B6]\]. More than 400 STEC serotypes have been described many of which are recoverable from faeces \[[@B7],[@B8],[@B9]\]. EHEC serotype O157:H7 is responsible for most cases of HUS particularly in the United States, Japan, Scotland, Canada and England. In the USA, O157:H7 EHEC infection causes approximately 73,000 illnesses resulting in several thousand hospitalizations and over 60 deaths per annum \[[@B10]\]. However, other EHEC serotypes including O26:H11/H- and O111:H8/H2/H- are also responsible for both large and sporadic outbreaks of serious disease worldwide \[[@B9],[@B11],[@B12]\]. EHEC O26:H^-^/H11 is a leading cause of HUS in many European countries \[[@B13],[@B14]\] and has recently been associated with severe paediatric cases \[[@B15]\]. The validity of antibiotic therapy in the treatment of EHEC infection is controversial \[[@B16],[@B17]\] with reports of antibiotics both inducing the SOS response and influencing the stability and subsequent release of Shiga toxin phage \[[@B18],[@B19]\]. Despite these concerns, the German Society for Infection recommended the use of antibiotics for the treatment of patients infected with O104:H4, responsible for the world's largest HUS outbreak \[[@B20]\].

Multiple antibiotic resistance in EHEC, particularly O157:H7, O26:H-/H11 and O111:H8, is a serious concern \[[@B21],[@B22],[@B23]\]. Genetic elements encoding multiple drug resistance (MDR) are often associated with complex antibiotic resistance gene loci (CRL) comprising mobile genetic elements, often located on transmissible plasmids of the IncI and IncF groups \[[@B24],[@B25]\]. IS*26* in association with Tn*3*-type transposons plays a particularly important role in the evolution of MDR plasmids and chromosomal islands in the *Enterobacteriaceae* \[[@B24],[@B26],[@B27],[@B28]\]. Homologous and site-specific recombination events involving these mobilizable CRL are shaping the rapid evolution of MDR in the gut microflora resulting in the more frequent isolation of complex mosaic plasmid backbones carrying multiple replicons, and antimicrobial drug resistance and virulence genes \[[@B24],[@B29]\].

In a previous study, we isolated multiply resistant EHEC and aEPEC by screening for atypical class 1 integrons where IS*26* abuts a truncated version of the 3´-CS (conserved segment) \[[@B30]\]. Multiply resistant EHEC O26:H- strain O6877, isolated from a patient with bloody diarrhoea, displays resistance to ampicillin (Ap), kanamycin (Km), streptomycin (Sm), sulfathiazole (Su), tetracycline (Tc) and trimethoprim (Tm), is toxigenic for Vero cells, enterohemolytic on washed sheep blood agar and carries Shiga toxin 1 (stx~1~), intimin (*eae*) and enterohemolysin (*ehxA*) genes \[[@B26],[@B31]\]. Virulence genes encoding enterohemolysin (EhxA), a putative adhesin (ToxB), a catalase/peroxidase (KatP), a serine protease (EspP), several proteins involved in biofilm formation (MsbB and ShdA) and a Tn*21* derivative, carrying antibiotic resistance genes encoding resistance to Ap-Km-Sm-Su-Tm, were shown to be located on an 111,481 bp MDR plasmid, pO26-CRL \[[@B26]\]. The Tn*21* derivate transposon houses an atypical integron containing a *dfrA5* cassette, encoding Tm resistance, and a truncated 3´-CS, followed by the complex MDR transposon Tn*6026*, containing *bla* ~TEM-1~, *aphA1*, *strAB*, and *sul2*, encoding resistance to Ap, Km/neomycin (Nm), Sm and Su respectively. The modified integron accounts for the antibiotic resistance phenotype of strain O6877 with the notable exception of Tc \[[@B26],[@B28]\]. Strain O6877 was earmarked for molecular characterization as it was representative of the subset of multidrug resistant *E. coli* containing these atypical class 1 integrons \[[@B30]\].

Here, we report the complete sequence of a 125 kb MDR plasmid, identified as pO26-CRL~125~, isolated from human O26:H- strain O6877. Like co-resident plasmid pO26-CRL (renamed here as pO26-CRL~111~), pO26-CRL~125~ confers resistance to Ap, Km, Sm, Su and Tm but it also encodes resistance to Tc. We also fully sequenced a 115 kb plasmid (pO111-CRL~115~) from O111 aEPEC strain D275, isolated from a bovine with gastrointestinal disease. pO111-CRL~115~ also shares the unique molecular signature created by IS*26*-mediated deletion affecting the structural integrity of the 3ʹ-CS. Our analyses show that plasmids pO26-CRL~125~ and pO111-CRL~115~ are essentially identical. These two plasmids were recovered from serologically different *E. coli*, belonging to different pathotypes, isolated from different animal hosts, yet remarkably share identical genetic architecture with substantial sequence similarity. Analyses of their minor sequence differences revealed several important aspects of *in vivo* plasmid evolution in pathogenic *E. coli* from different hosts.

Materials and Methods {#s2}
=====================

Bacterial strains and plasmids {#s2.1}
------------------------------

EHEC O26:H- strain O6877 was originally isolated in 1998 \[[@B31]\] and carries two MDR plasmids, pO26-CRL~111~ described earlier \[[@B26]\] and pO26-CRL~125~ (described here). Strain O6877 and O111 aEPEC strain D275 (isolated between 1999 and 2002) were part of a larger collection of 512 serologically diverse MDR *E. coli* including aEPEC, STEC and EHEC of human and bovine origin that were screened for the presence of class 1 integrons \[[@B30]\]. Plasmids pO26-CRL~125~ and pO111-CRL~115~ were isolated from O6877 and D275 respectively and sequenced.

Plasmid isolation {#s2.2}
-----------------

Plasmids from *E. coli* strains O6877 and D275 were conjugated with *E. coli* DH5α as previously described \[[@B32]\]. Gel electrophoresis of plasmid preparations showed that the wildtype strains carried several plasmids of different molecular size. As this potentially complicates sequencing studies, purified plasmid preparations from each strain were used in transformation using *E. coli* TOP10 as recipient following standard protocols (Invitrogen, Mulgrave, Vic, Australia). Transconjugants and transformants were tested for resistance to appropriate panels of antibiotics as described previously \[[@B26]\] and examined by gel electrophoresis to ensure each carried a single plasmid species.

Sequencing {#s2.3}
----------

Plasmids were isolated from *E. coli* DH5α or TOP10 hosts using the plasmid Midi Prep extraction kit (Qiagen, Doncaster, Vic, Australia). Plasmid sequencing was performed using Roche 454 GS FLX technology at the Ramaciotti Center for Gene Function Analysis. MDR plasmids were multiplexed with equal total DNA concentrations providing approximately 25 to 700x sequence coverage. Plasmids pO26-CRL~125~ and pO111-CRL~115~ were sequenced to 49 and 25x coverage, respectively. Plasmid sequences were assembled *de novo* using the Newbler v2.3 software package (454 Life Sciences, a Roche company, Branford, CT, USA). Contigs were broken by long repeat sequences, typically IS*26* and were assembled into a single sequence by PCR between adjacent contigs. Contaminant chromosomal sequences were present at significantly reduced coverage, typically less than 3x. Plasmid contigs were initially annotated automatically using the RAST server \[[@B33]\]. Subsequently, the annotation was manually curated.

Sequence analysis {#s2.4}
-----------------

For sequence analysis and manual annotation, the BLAST algorithm \[[@B34]\] ([[www.ncbi.nlm.nih]{.ul}](http://www.ncbi.nlm.nih).[gov]{.ul}/BLAST), insertion sequence (IS) finder \[[@B35]\] (www-is.biotoul.fr), open reading frame (ORF) finder (www.ncbi.nlm.nih.gov/projects/gorf), and the VectorNti software program (Invitrogen, Mulgrave, Vic, Australia) were utilized. EMBOSS Needle alignment tool ([[http://www.ebi.ac.uk/Tools/psa/emboss_needle/]{.ul}](http://www.ebi.ac.uk/tools/psa/emboss_needle/)) and ClustalO \[[@B36]\] (http://www.ebi.ac.uk/Tools/msa/clustalo) were used for nucleotide and protein sequence comparison. Protein sequences were characterized using the Pfam database ([[http://pfam.sanger.ac.uk/]{.ul}](http://pfam.sanger.ac.uk/)) for annotation of protein function. Circular representations of the plasmids, including comparisons to related plasmids were made using CGview \[[@B37]\].

Stability assays {#s2.5}
----------------

Stability experiments were performed essentially as previously described \[[@B38]\]. Briefly, overnight cultures in LB Tc (20 μg/ml) of transformed *E. coli* TOP10 strains harboring pO26-CRL~125~ or pO111-CRL~115~ (37 °C with shaking) were washed to remove the antibiotics and resuspended in saline. Each day 4.88 μl from fresh cultures were transferred to 5 ml LB in order to obtain about 10 generations per 24 h growth cycle (37 °C with shaking at constant speed). At selected time points, the growing cultures were plated both onto LB agar and LB agar supplemented with Tc (20 μg/ml) and incubated overnight at 37 °C. Determining the fraction of plasmid free cells in the population was done by calculating the ratio between the total number of cells (LB only) and the number of plasmid-containing cells (LB Tc). For each strain, stability experiments were performed in triplicate over 80 generations. The data were plotted using the Graph Pad Prism software (Graph Pad Software, Inc., San Diego, CA, US).

Conjugal transfer of pO111-CRL~115~ and pO26-CRL~125~ into JM109 Rif^r^Nal^r^ *E. coli* {#s2.6}
---------------------------------------------------------------------------------------

Conjugal capacity of pO26-CRL~125~ and pO111-CRL~115~ was tested by mating the *E. coli* TOP10 transformants with JM109 Rif^r^Nal^r^, a recipient rifampicin resistant *E. coli* JM109 made resistant to nalidixic acid (Nal) by multiple subculture on selective LB agar with increasing Nal concentrations (2 to 30 μg/mL). To confirm conjugation frequencies, a second assay was carried out following the same protocol with the inclusion in the mating mixture of *E. coli* HB101 containing the chloramphenicol resistant conjugative helper plasmid pRK600 \[[@B39]\] (not shown). Transconjugants were plated onto LB agar co-selecting for both the MDR plasmid (Ap, 100 μg/ml) and the recipient JM109 Rif^r^Nal^r^ (Nal 30 μg/ml). Each mating was also plated onto LB agar selecting for the recipient only (Nal 30 μg/ml). Donor only and recipient only negative controls were also plated onto the same media. The conjugal transfer frequency was calculated as the number of transconjugants per number of recipient cells. Transconjugants were tested for resistance on media supplemented with the following antibiotics: Rif (100 μg/ml), Ap (32 μg/ml), Km (10 μg/ml), Tc (20 μg/ml), and Su (550 μg/ml).

Nucleotide sequences accession number {#s2.7}
-------------------------------------

The complete nucleotide sequences for pO26-CRL~125~ and pO111-CRL~115~ have been submitted to the GenBank database under accession numbers KC340959 for pO111-CRL~115~ and KC340960 for pO26-CRL~125~.

Results {#s3}
=======

Sequence analysis of pO26-CRL~125~ and pO111-CRL~115~ {#s3.1}
-----------------------------------------------------

pO26-CRL~125~ and pO111-CRL~115~ comprise 124,908 bp and 115,452 bp respectively. Both display an average G + C content of about 53%, around 2.5-3% higher than the G + C content of sequenced *E. coli* O26 and O111 chromosomes \[[@B40]\]. The general structure of pO26-CRL~125~ and pO111-CRL~115~ is shown in [Figure 1](#pone-0078862-g001){ref-type="fig"}. The two plasmids are almost identical except for: i) a 9,726 bp fragment found only in pO26-CRL~125~ (leading region), ii) differences in the number of repeats in two unrelated repeat regions (RD1 and RD2), iii) a 135 bp deletion in the *traH* open reading frame (orf) in pO26-CRL~125~ (RD3), iv) one small indel and two point mutations ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Table 1](#pone-0078862-t001){ref-type="table"}). pO26-CRL~125~ and pO111-CRL~115~ contain 147 and 136 predicted orfs respectively ([Table S1](#pone.0078862.s003){ref-type="supplementary-material"}). The plasmid backbones encode genes for replication, stability and maintenance, and conjugal transfer ([Figure 2](#pone-0078862-g002){ref-type="fig"}; [Table S1](#pone.0078862.s003){ref-type="supplementary-material"}), and display a mosaic structure where modules characteristic of plasmids belonging to different incompatibility types are assembled in a novel arrangement. Large portions of the backbones share high sequence identity (\>95%) with IncI EHEC plasmids, such as IncI1 pO113 (GenBank AY258503) ([Figure 2](#pone-0078862-g002){ref-type="fig"}), with some modules showing homology to specific elements of plasmids belonging to incompatibility groups IncZ (pIE545; GenBank M93064.1), IncB (p3521; GenBank GU256641) and IncP-1α (pBS228; GenBank NC_008357) ([Figure 1](#pone-0078862-g001){ref-type="fig"}). In this mosaic backbone structure, divergent G + C content for separate regions suggests assembly by multiple horizontal gene transfer events ([Figure 1](#pone-0078862-g001){ref-type="fig"}). The accessory gene load in both plasmids consists of a CRL containing derivate Tn*21* and Tn*1721* transposons, and a virulence module, encoding putative virulence factors, including a novel serine protease autotransporter of *Enterobacteriaceae* (SPATE) ([Figure 2](#pone-0078862-g002){ref-type="fig"}).

![Main distinguishing features of plasmids pO26-CRL~125~ and pO111-CRL~115~.\
**a**. Schematic visualization of gene arrangement in pO26-CRL~125~ and pO111-CRL~115~. Genes with known function and competency modules are indicated by name. Overall mean G + C content is indicated in percentages (GC%). Highest sequence homology to specific Inc groups is indicated by labeled horizontal brackets. RD1, RD2 and RD3 indicate the position of the regions of sequence where pO26-CRL~125~ and pO111-CRL~115~ differ substantially. Potential recombination signatures were identified by BLAST analysis. Regions of interest in plasmid architecture are labeled with red boxes (bold italics). b Depiction of the unique shufflon found in pO111-CRL~115~ and pO26-CRL~125~. This module presents a single invertible fragment selecting for two possible PilV C-termini. The sequence of the characteristic 19 bp repeats, thought to be involved in the site-specific recombination events leading to *pilV* inversions, is shown. Drawings not to scale.](pone.0078862.g001){#pone-0078862-g001}
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###### Sequence differences between *E. coli* plasmids pO26-CRL~125~ and pO111-CRL~115~.

  **Label\***   **Gene/Feature**             **pO111-CRL~115~ nt^+^ position**   **pO26-CRL~125~ nt^+^ position**   **Modification pO111-CRL~115~/pO26-CRL~125~**
  ------------- ---------------------------- ----------------------------------- ---------------------------------- -----------------------------------------------
  RD1           *oriV*-IncP repeat region    28488 - 28648                       28488                              \+ / - 160 bp
  RD2           8 bp tandem repeats          37664                               37504 - 37520                      \- / + 16 bp
  mut 1         non coding                   40761                               40617                              C / T
  mut 2         *hap* (silent)               45075                               44931                              T / C
  LR            IncI1 leading region         48975                               48832 - 58557                      \- / + 9,726 bp
  RD3           *traH* (in frame deletion)   94053 - 94188                       103633                             \+ / - 135 bp
  indel         non coding                   97000                               106446 - 106456                    \- / + 10 bp

\* RD, region of difference; LR, leading region; mut, point mutation; indel, insertion-deletion. ^+^nt, nucleotide.

![Circular representation of plasmid pO26-CRL~125~.\
The outer two circles (+ and − strands) show the coding sequences of plasmid pO26-CRL~125~, colored according to broad function. The two inner circles represent BLAST comparisons to pO111-CRL~115~ (pale maroon circle) and EHEC plasmid pO113 (GenBank AY258503) (pale green innermost circle), where the color shading is reflective of the similarity in nucleotide sequence. pO111-CRL~115~ contains the same complex multidrug resistance locus encoding resistance to seven antibiotics and comprising both a Tn*21* derivative transposon and a truncated Tn*1721* (red block arrows). Genes associated with virulence (purple/pink arrows) are almost all clustered in one position. Operons involved in conjugal transfer mechanisms (green arrows) show high homology to the same modules in pO113. The main regions of interest in the architecture of these plasmids (multi-resistance region, leading region and SPATE) are labeled with brackets. Figure prepared using CGView \[[@B37]\].](pone.0078862.g002){#pone-0078862-g002}

IncZ and IncQ replicons {#s3.2}
-----------------------

pO26-CRL~125~ and pO111-CRL~115~ contain two separate replication regions, a complete IncZ replicon identical to that of pIE545 (GenBank M93064.1) from *Klebsiella pneumoniae* and a partial IncQ replicon within the Tn*21* derivative transposon in the antibiotic resistance module ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Figure 3](#pone-0078862-g003){ref-type="fig"}). The IncZ replicon contains genes coding for RepZ and RepY proteins and an RNAI encoding sequence with homology to that of other plasmids of the IncI complex ([Table S1](#pone.0078862.s003){ref-type="supplementary-material"}; [Figure S1a](#pone.0078862.s001){ref-type="supplementary-material"}). Inc RNAI encodes antisense RNA for *repYZ* mRNA and is one of the elements responsible for plasmid incompatibility \[[@B41],[@B42]\]. IncZ plasmids are compatible with IncI1 and IncK plasmids but incompatible with IncB plasmids \[[@B41]\]. Consistent with these reports, IncZ plasmid pO26-CRL~125~ (this study) and IncI1 plasmid pO26-CRL~111~ \[[@B26]\] are co-resident in O26:H- EHEC strain O6877 and appear to be stably maintained. In both pO26-CRL~125~ and pO111-CRL~115~, the defective IncQ replicon, comprising the *repC* gene and a partial *repA* sequence, is identical to the IncQ replicon in the Tn*21* derivative transposon of plasmid pO26-CRL~111~ ([Figure 3](#pone-0078862-g003){ref-type="fig"}).

![Map of the complex multiple resistance locus (CRL) of pO26-CRL~125~ and pO111-CRL~115~ and schematic representation of its insertion site within the *col* operon.\
The CRL comprises a Tn*21* derivate, encoding resistance to six antibiotics - *aphA1* (kanamycin and neomycin), *strA-strB* (streptomycin), *sul2* (sulfathiazole), *bla* ~TEM-1~ (ampicillin), and *dfrA5* (trimethoprim) - and to mercuric chloride (*mer* operon), and a truncated Tn*1721* (ΔTn*1721*) transposon encoding *tetA*(A) (resistance to tetracycline). The Tn*21* derivative contains a modified class 1 integron, carrying the *dfrA5* cassette, but missing the 3´-CS due to IS*26*-mediated insertion of transposon Tn*6026*. Tn*6026* harbors a copy of Tn*6029*, comprising a truncated Tn*2* with *bla* ~TEM-1~ and an RSF1010 segment with *strA-strB* and *sul2*, and a copy of Tn*4352* carrying *aphA1*. In pO111-CRL~115~, Tn*21* and ΔTn*1721* are separated by a region identical to the *oriV* of the IncP-1α pBS228 (GenBank NC_008357). IncP plasmids have a very specific and well characterized *oriV*, comprising a G/C rich region, an A/T rich region, several tandem direct repeats (iterons) and host factors (DnaA, IHF) binding motifs . In pO111-CRL~115~, as in pBS228, one IHF and three DnaA (DnaA boxes) binding sites plus nine iterons are present. In pO26-CRL~125~, part of this *oriV* sequence, with iterons 5 and 4, two DnaA boxes and the IHF binding motif, is deleted (red frame). The boundaries of the CRL components are labeled with brackets. The insertion point of the multiple resistance locus within the *colIb* operon is shown in the figure. Transcriptional direction is indicated by arrows. Δ denotes a partially deleted or truncated gene. IR denotes inverted repeats: IR~IS26~, inverted repeats of IS*26*; IR~t-In2~ and IR~i-In2~ inverted repeats flanking the class 1 integron found within transposon Tn*21*; IR~*mer21*~, 38 bp inverted repeat of transposon Tn*21* adjacent to the *merR* gene; IR~*tnp21*~, 38 bp inverted repeat of transposon Tn*21* adjacent to the *tnpA* gene; IR~*tet1721*~, 38 bp inverted repeat of transposon Tn*21* adjacent to the *ΔtnpA* gene. Drawing not to scale.](pone.0078862.g003){#pone-0078862-g003}

The sequence separating the IncZ *oriV* from the downstream CRL shows homology to ColIb plasmids sequence (99%), except for a 3 kb fragment with low G + C content (41%) containing five orfs with little or no nucleotide homology to known sequences ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Table S1](#pone.0078862.s003){ref-type="supplementary-material"}). A BLASTn search against sequences deposited in the NCBI database revealed two gaps in alignment bordering the 5´ and 3´ flanks of this intervening sequence likely representing DNA recombination signatures. Two of these orfs encode a putative novel StbD/E type II antitoxin/toxin system with homology to the RelB/E toxin-antitoxin stability systems of *E. coli* and other Gram-negative species \[[@B43],[@B44]\]. The StbD antitoxin partner belongs to the PHD antitoxin family but showed no specific amino acid homology to the RelB component, while the predicted StbE protein showed 80 to 95% identity with representatives of the characterized cytotoxic translational repressor RelE of *E. coli* \[[@B43]\].

IncI modules form the majority of the plasmid backbone {#s3.3}
------------------------------------------------------

The backbone of pO111-CRL~115~ and pO26-CRL~125~ contains plasmid maintenance, stability and transfer modules characteristic of IncI plasmids. The maintenance and stability modules of the two plasmids are identical ([Figure 2](#pone-0078862-g002){ref-type="fig"}) except for a difference (RD2) in the number of contiguous repeats (8 bp; *aacaagat*) found in a set between the *col* operon and the *parA* gene ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Table 1](#pone-0078862-t001){ref-type="table"}). Sequence comparison with other IncI plasmids in the NCBI database identified alignment gaps in the RD2 region, indicating a potential recombination hotspot. The transfer modules in pO26-CRL~125~ and pO111-CRL~115~ are also virtually identical and contain type IV conjugative transfer operons sharing extensive nucleotide sequence identity (95-100%) with the transfer regions of pO113 (GenBank AY258503) ([Figure 2](#pone-0078862-g002){ref-type="fig"}). These modules comprise the *traABC* regulatory genes (\~4 kb), the *pil* operon for thin pilus biogenesis (*pilI* to *pilV*; \~13 kb), and *trb*/*tra* genes for conjugal transfer (\~29 kb). The *oriT* region, including the *nikA* and *nikB* genes and the 85 bp *oriT* sequence identical to the *oriT* of IncB plasmid p3521 (GenBank GU256641; [Figure 1](#pone-0078862-g001){ref-type="fig"}), was located in close proximity to the *trb* operon as in other IncI plasmids (R64 GenBank AP005147; pO113 GenBank AY258503; ColIb-P9 GenBank NC_002122.1). The *oriT* specific sequence with its two sets of imperfect repeats was identified by comparison with the well characterized *oriT* of IncI1 plasmid R64 \[[@B45]\] ([Figure S1b](#pone.0078862.s001){ref-type="supplementary-material"}). The *tra* operon presents the same gene arrangement observed in pO113 except for 1 kb of sequence between *traU* and *traT* displaying no nucleotide identity with other IncI plasmids. The *traH* sequence of pO111-CRL~115~ is identical to that in pO113 and unique to these plasmids. In pO26-CRL~125~, a 135 bp deletion (45 amino acids) was identified in this orf (RD3; [Table 1](#pone-0078862-t001){ref-type="table"}). This deletion does not disrupt the reading frame in the putative *traH* gene, therefore a functional conserved lipoprotein product can still be expressed in both plasmids.

The nucleotide sequence of the shufflon recombinase that follows the *tra* operon presents no homology to pO113 but is almost identical (92%) to a gene found in a phage sequence from *Salmonella enterica* serovar Hadar ICESe4 (GenBank FR686852). The unique shufflon of pO26-CRL~125~ and pO111-CRL~115~ consists of a single invertible segment ([Figure 1b](#pone-0078862-g001){ref-type="fig"}) that represents the 3´ variable portion of the PilV adhesin. Shufflons previously described in IncI plasmids contain four (A, B, C, D) or three 3´-terminal segments (A, B, and C or D) of the *pilV* orf \[[@B42],[@B46]\], while the pO111-CRL~115~ and pO26-CRL~125~ shufflon contains only a B homologous segment and a second region with unique nucleotide sequence encoding an homolog of shufflon protein C ([Figure 1b](#pone-0078862-g001){ref-type="fig"}; [Table S1](#pone.0078862.s003){ref-type="supplementary-material"}). The only other shufflons presenting a single invertible portion have been described in *Salmonella enterica* serovar Typhi \[[@B46]\] and in *S. enterica* serovar Hadar ICESe4 (GenBank FR686852).

Structure of the complex antibiotic resistance module {#s3.4}
-----------------------------------------------------

Plasmids pO26-CRL~125~ and pO111-CRL~115~ were isolated from pathogenic *E. coli* of human and bovine origin by PCR amplifying the 3´-CS boundary of atypical class 1 integrons. This PCR, which has one primer in *intI1* and another in IS*26*, produced identical 848 bp amplicons indicating that both these plasmids carried a similar derivative Tn*21* transposon to that previously found in O26:H- EHEC strain O6877 \[[@B26],[@B30]\]. pO26-CRL~125~ and pO111-CRL~115~ harbour identical CRL comprising a derivate Tn*21* transposon and a truncated version of Tn*1721* (ΔTn*1721*) separated by a IncP-1α *oriV* sequence ([Figure 3](#pone-0078862-g003){ref-type="fig"}). The Tn*21* derivative transposon in these two plasmids shares 100% sequence identity with the Tn*21* derivate in pO26-CRL~111~ (GenBank GQ259888). The mercury resistance module (*merRTPCAD*) and the complete Tn*21* transposition module (*tnpA*, *tnpR*, and *tnpM*) frame a central antibiotic resistance gene cluster comprising a modified class 1 integron. The integron carries a *dfrA5* resistance gene cassette, encoding Tm resistance, and Tn*6026*. Tn*6026* contains *bla* ~TEM-1~, *strAB*, *sul2* and *aphA1*, encoding resistance to Ap, Sm, Su, Km/Nm respectively ([Figure 3](#pone-0078862-g003){ref-type="fig"}) \[[@B26],[@B28]\]. Tn*6026* lies precisely 24 bp downstream of the beginning of the 3´-CS in both pO26-CRL~125~ and pO111-CRL~115~ as it does in pO26-CRL~111~ \[[@B26]\].

In pO111-CRL~115~, a region encoding an A/T rich segment and nine tandem repeats, identical to the vegetative origin of replication (*oriV*) of the IncP-1α plasmid pBS228 of *Pseudomonas aeruginosa* (GenBank NC_008357) \[[@B47]\], separates the *mer* module of the Tn*21* derivative transposon from ΔTn*1721* ([Figure 3](#pone-0078862-g003){ref-type="fig"}). The *oriV*-∆Tn*1721* sequence displays a G + C content of approximately 63% suggesting it was acquired by lateral transfer. IncP plasmids possess a very specific and well characterized *oriV* ([Figure 3](#pone-0078862-g003){ref-type="fig"}) \[[@B48]\]. A functional IncP replicon depends on the interaction between the *oriV* locus and the *trfA* gene products \[[@B48]\], but *trfA* was not present in either pO111-CRL~115~ or pO26-CRL~125~. In pO26-CRL~125~, the IncP-*oriV* sequence is identical to that of pO111-CRL~115~ except for 160 bp of missing sequence, containing two DnaA binding sites, one IHF binding moiety and iterons five and four (RD1) ([Figure 3](#pone-0078862-g003){ref-type="fig"}). In both pO26-CRL~125~ and pO111-CRL~115~, the junction between *oriV* and ΔTn*1721* is identical to that found in pBS228 (GenBank NC_008357; [Figure 3](#pone-0078862-g003){ref-type="fig"}). Also, the *tetR* and *tetA*(A) genes for tetracycline resistance and the *pecM* orf within ΔTn*1721* are identical to both the Tn*1721* prototype sequence (GenBank X61367) \[[@B49]\] and the same genes found in pBS228. Unlike pBS228, however, in both plasmids a truncated version of the Tn*1721 tnpA* gene (∆*tnpA*) is present. Database searches indicated that sequence identical to the entire ΔTn*1721* module is specifically found in IncP-1β plasmid pB10 (GenBank NC_004840) and in IncN plasmid pRSB201 (GenBank JN102341.1), both recovered from wastewater \[[@B50],[@B51]\].

In pO26-CRL~125~ and pO111-CRL~115~, the 5´ and 3´ sequences flanking the CRL were virtually identical to orfs associated with the colicin operon in IncI plasmids (98 to 100% nucleotide identity to ColIb-P9 and pO113) ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Figure 3](#pone-0078862-g003){ref-type="fig"}). Comparative analysis with the homologous region of ColIb plasmids showed deletion of the 3´ end of the conserved *yagA* orf of unknown function, and of the 5´ end of the adjacent *colIb* gene, responsible for the production of colicin Ib ([Figure 3](#pone-0078862-g003){ref-type="fig"}). Insertion of Tn*21*-RD1-∆Tn*1721* in the *col* operon is unique to pO26-CRL~125~ and pO111-CRL~115~. However, in other IncI plasmids, IS and other mobile genetic elements are known to insert in this same location \[[@B42],[@B52]\]. No identical matches to either the CRL in pO111-CRL~115~ or in pO26-CRL~125~, with the iteron deletions, were found in public databases. However, the arrangement of these CRL is consistent with observations that the *oriV*-*trfA* junction acts as a hot spot for the insertion of antibiotic resistance transposons and IS in the IncP backbone \[[@B53],[@B54]\]. In pO26-CRL~125~ and pO111-CRL~115,~ target repeats characteristic of Tn*21* or Tn*1721* transposition are missing at the CRL insertion site. This indicates that homologous recombination events may have played here a role in the formation of the Tn*21*-RD1-∆Tn*1721* CRL.

Virulence module: novel serine protease autotransporter sequence {#s3.5}
----------------------------------------------------------------

pO26-CRL~125~ and pO111-CRL~115~ contain several genes encoding both putative and established *E. coli* virulence factors ([Figure 2](#pone-0078862-g002){ref-type="fig"}; [Table S1](#pone.0078862.s003){ref-type="supplementary-material"}). An almost complete *col* operon, encoding bacteriocidal properties as well as host-specific colicin immunity \[[@B55]\], is found immediately adjacent to ∆Tn*1721* ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Figure 3](#pone-0078862-g003){ref-type="fig"}). In both plasmids, five genes, with putative roles in virulence, were identified clustered together in the region between the *trb* and *tra* operons as in EHEC plasmid pO113 \[[@B56]\] ([Figure 1](#pone-0078862-g001){ref-type="fig"}; [Figure 2](#pone-0078862-g002){ref-type="fig"}). Among these is a 4,089 bp orf that encodes a novel SPATE. Sequence analysis shows that the putative protein product displays all the features characteristic of SPATEs \[[@B57]\], including a signal peptide sequence, a peptidase S6 domain, a functional passenger domain, and a β-barrel autotransporter domain ([Figure S2](#pone.0078862.s002){ref-type="supplementary-material"}). At the nucleotide level the gene shows only partial identity with known sequences and presents a unique nucleotide sequence for the peptidase S6 and passenger domains. At the amino acid level, the autotransporter domain is identical to that of EspP and EspC from EHEC, while the passenger domain shares 33% sequence identity with EspP of *E. coli* O157:H7 strain Sakai (GenBank NP_052685.1) ([Figure S2](#pone.0078862.s002){ref-type="supplementary-material"}).

A 9.7 kb element distinguishes pO26-CRL~125~ from pO111-CRL~115~ {#s3.6}
----------------------------------------------------------------

The 9,726 bp fragment present in pO26-CRL~125~ contains an IncI-associated genetic module implicated in the stable establishment in recipient cells following conjugation. This fragment is found in most IncI conjugative plasmids and contains an *ssb* gene coding for a single-stranded DNA (ssDNA) binding protein, a *parB* homolog for plasmid partitioning, *psiB* and *psiA* genes encoding SOS-response inhibition functions, and the conserved *ardA* and *ccgAII* orfs both with antirestriction function \[[@B42]\]. *ccgAII* is adjacent to a transposase encoding gene and four orfs with unknown function ([Figure 4a](#pone-0078862-g004){ref-type="fig"}; [Table S1](#pone.0078862.s003){ref-type="supplementary-material"}). Sequence analysis of the 9.7 kb region of pO26-CRL~125~ revealed the presence of three imperfect repeats (R1, R2, R3) with homology to the ssDNA promoter *Frpo* sequence ([Figure 4b](#pone-0078862-g004){ref-type="fig"}) \[[@B58],[@B59]\]. The 9.7 kb module was entirely missing in the pO111-CRL~115~ backbone, but continuous sequence (R1~pO111~) almost identical to the pO26-CRL~125~ repeats was found at the point of insertion of the missing fragment ([Figure 4a](#pone-0078862-g004){ref-type="fig"}). The R1~pO111~ sequence in fact is identical to parts of both R1 (bases 1 to 239) and R3 (last 222 bases). These observations are consistent with the 9.7 kb fragment inserting via a double reciprocal crossover event. *Frpo*-containing sequences in sequenced IncI1 family plasmids are always associated with leading region genes exactly as seen in pO26-CRL~125~ ([Figure 4a](#pone-0078862-g004){ref-type="fig"}) or with minor variations, and are mostly located in proximity to DNA modifying genes and the *oriT* and *nikAB* orfs as seen in both pO26-CRL~125~ and pO111-CRL~115~ ([Figure 4a](#pone-0078862-g004){ref-type="fig"}). Variants may contain transposase or IS elements between repeats (pETEC_73 GenBank NC_009788.1; R621a GenBank NC_015965.1; p746 GenBank NC_014234.1) or the *hok*-*mok* post-segregational killing system replacing the *ccgAII* gene (p1658/97 GenBank NC_004998.1; p53638_75 GenBank NC_010720.1). Uniquely in pO111-CRL~115~, R1~pO111~ was not associated with any of the leading region components.

![Schematic representation of the IncI leading region of pO26-CRL~125~.\
**a**. A 9.7 kb fragment, carrying genes involved in plasmid establishment in recipient cells during the early phases of conjugation, is the main distinguishing feature between pO26-CRL~125~ and pO111-CRL~115~. The insertion point in the backbone shared by pO26-CRL~125~ and pO111-CRL~115~ is indicated. The genes in the leading region are transcribed in the same direction (black arrows) from the single-stranded DNA promoter *Frpo* located in imperfect direct repeat sequences (R). The pO111-CRL~115~ sequence contains a R sequence (R~pO111~) identical to portions of both R1 and R3, but no leading region genes. Drawing not to scale. **b**. Alignment of R sequences found in pO26-CRL~125~ and pO111-CRL~115~ with *Frpo* containing sequences from IncI plasmids ColIb-P9 (GenBank NC_002122) and R64 (GenBank AP005147). The base differences between repeat sequences are highlighted in yellow. Alignment was obtained using the EMBO ClustalO online tool \[[@B36]\] (<http://www.ebi.ac>. uk/clustalO).](pone.0078862.g004){#pone-0078862-g004}

In order to determine whether the differences in the sequence of pO111-CRL~115~ and pO26-CRL~125~ compromise the ability of each plasmid to mobilize and establish in recipient cells, plasmid conjugation and stability experiments were performed in parallel. In mating assays using *E. coli* JM109 Rif^r^Nal^r^ as recipient strain, both plasmids were able to self-transfer and showed comparable conjugation frequency ([Table 2](#pone-0078862-t002){ref-type="table"}). In transformed *E. coli* TOP10 strains, no significant difference in stability between pO111-CRL~115~ and pO26-CRL~125~ was observed after 80 generations ([Figure 5](#pone-0078862-g005){ref-type="fig"}).

10.1371/journal.pone.0078862.t002

###### Conjugal transfer of plasmids pO26-CRL~125~ and pO111-CRL~115~.

  ***E. coli* strains**                         **No selection**      **Amp + Nal**      **Nal**       **Conjugation frequency**
  --------------------------------------------- --------------------- ------------------ ------------- ---------------------------
  TOP10 (pO26-CRL~125~)                         1.2 x 10^9^           \-                 \-            NA
  TOP10 (pO111-CRL~115~)                        1.1 x 10^9^           \-                 \-            NA
  JM109 Rif^r^Nal^r^                            1.4 x 10^9^           \-                 3.8 x 10^9^   NA
  TOP10 (pO26-CRL~125~) + JM109 Rif^r^Nal^r^    NA                    7 x 10^5^          2.1 x 10^9^   3.3 x 10^-4^
  TOP10 (pO111-CRL~115~) + JM109 Rif^r^Nal^r^   NA                    1.3 x 10^6^        3.5 x 10^9^   3.7 x 10^-4^

NA, not applicable; Amp, ampicillin (100 μg/ml); Nal, rifampicin (30 μg/ml); -, no transconjugants detected.

![Stability curves.\
Stability of plasmids pO26-CRL~125~ and pO111-CRL~115~ was assessed over 80 generations by subculture in LB and selection on tetracycline supplemented solid media over 8 consecutive days. Both plasmids showed comparable high degrees of stability. Error bars indicate mean and standard deviation (*n* = 3).](pone.0078862.g005){#pone-0078862-g005}

Discussion {#s4}
==========

The O26:H- EHEC strain O6877 is resistant to Ap, Km, Nm, Sm, Su, Tm and Tc and has been implicated as the causative agent of haemorrhagic colitis in an elderly patient \[[@B31]\]. We showed that two MDR plasmids, one a 124,908 bp IncZ plasmid pO26-CRL~125~ reported here, and a second 111,481 bp IncI1 plasmid pO26-CRL, renamed pO26-CRL~111~, reported earlier \[[@B26]\], co-exist in strain O6877. These plasmids carry different virulence gene combinations and plasmid incompatibility markers, but all genes encoding antibiotic resistance except for Tc are localized within the IR boundaries of identical derivate Tn*21* transposons. Five base pair direct repeats characteristic of Tn*21* transposition sites were found flanking the derivative transposon in the *traC* gene in pO26-CRL~111~ \[[@B26]\], but not in pO26-CRL~125~ or related plasmid pO111-CRL~115~. The transposition (*tnpA*) and resolvase (*tnpR*) genes and the IR~*tnp21*~ and IR~*mer21*~ inverted repeats are intact in pO26-CRL~125~. In EHEC strain O6877, it is likely that the derivate Tn*21* CRL originated in pO26-CRL~125~ and transposed into pO26-CRL~111~. STEC are readily isolated from the faeces of all ruminant species and many carry the enterohaemolysin gene *ehxA* on large plasmids that also carry other virulence genes \[[@B6],[@B7],[@B8],[@B60]\]. The spread of the derivate Tn*21* transposon described in this study represents a mechanism by which virulence plasmids widely found in ruminant STEC populations can rapidly acquire resistance to multiple antibiotics in a single transposition event and is cause for serious concern. Little is known about the lateral transfer of EHEC plasmids and derivate mercury resistant transposons harboring CRL, between different pathotypes of *E. coli*. Recent studies provide evidence that food-producing animals represent one of the major reservoirs of *E. coli* causing urinary tract infections (UTI) \[[@B61]\]. Although antibiotics have limited use in the treatment of diarrheagenic *E. coli* infections, they are critical for management of extraintestinal infections.

In this study, we also reported the complete sequence of a large MDR plasmid, named pO111-CRL~115~, isolated from bovine O111 aEPEC strain D275. Bovine strain D275 is resistant to the same panel of antibiotics as human O26:H- EHEC strain O6877 and was positive for a diagnostic PCR we developed to detect atypical class 1 integrons \[[@B30]\]. The PCR, which has one primer in *intI1* and another in IS*26*, produced an 848 bp amplicon indicating that D275 carried a similar derivative Tn*21* transposon to that found in O26:H- EHEC strain O6877 \[[@B26],[@B30]\]. The same 848 bp amplicon was previously identified in a group of serologically diverse multiply antibiotic resistant *E. coli* from cattle on farms located far apart on the east coast of Australia and in two isolates recovered from human UTI patients \[[@B30]\]. More recently, we also identified the 848 bp amplicon using the *intI1*-IS*26* PCR in several clinical isolates \[[@B62]\]. Composite transposons such as Tn*6029*/Tn*6026*, that carry *bla* ~TEM~, *strAB*, and *sul2* genes flanked by IS*26*, are globally disseminated and contribute to the evolution of CRL \[[@B26],[@B28],[@B63],[@B64]\].

In this study, we showed that pO111-CRL~115~ carries an identical copy of the derivate Tn*21* transposon found in pO26-CRL~125~ and pO26-CRL~111~. The CRL in pO26-CRL~125~ and pO111-CRL~115~ starts at the IR~*tnp21*~ and ends with IR~*tet1721*~. Tn*21* and Tn*1721* both belong to the Tn*3* family of transposons. Consequently, transposase-IR regions and their resolvases are functionally interchangeable and both generate 5 bp direct repeats at the site of transposition \[[@B65],[@B66]\]. The structure of the CRL described here and the lack of 5 bp direct repeats suggest a complex evolutionary history involving laterally acquired DNA derived from disparate plasmids with different incompatibility, assembling within the IR boundaries via homologous recombination. These data reveal the critical role of derivate Tn*21* transposons in spreading CRL among diverse plasmids carrying different virulence gene combinations in *E. coli* belonging to different pathotypes. PCR targeting key loci that arise during the molecular evolution of CRL can be exploited to track mercury resistance transposons containing CRL and the plasmids that carry them. We provide direct evidence of the latter here.

Despite their different host origins, pO26-CRL~125~ and pO111-CRL~115~ are essentially identical plasmids. The main difference between them is a 9,726 bp fragment found only in pO26-CRL~125~. The 9,726 bp fragment, known as the IncI1 leading region, is characteristic of large IncI conjugative plasmids and contains a number of genes, including *ardA*, *psiAB*, and *ssb*, that function, often in a host-specific manner, during conjugation to protect single stranded DNA as it first enters the recipient cell \[[@B67],[@B68],[@B69]\]. The SOS response is known to influence the frequency of genetic rearrangement, particularly within integrons, as well as protect bacteria from external stresses in promiscuous environments \[[@B68],[@B70]\]. Trimethoprim and β-lactam antibiotics are known to induce the SOS response \[[@B18]\]. The leading region genes are transiently expressed during conjugation and their expression is regulated by the specific *Frpo* promoter situated within repeat regions (R1, R2 and R3 in pO26-CRL~125~) \[[@B59]\]. To our knowledge, pO111-CRL~115~ is the first plasmid shown to completely lack the 9.7 kb fragment, but retain a *Frpo* sequence located exactly where the pO26-CRL~125~ leading region inserts. This suggests that the 9.7 kb fragment may actually be a novel mobile element. The presence of a putative transposase gene in the leading region sequence adds some weight to this speculation. We were unable to detect any difference in the conjugative efficiencies of pO111-CRL~115~ and pO26-CRL~125~ in standard laboratory conditions ([Table 2](#pone-0078862-t002){ref-type="table"}). Further studies are needed to characterize the function of the 9,726 bp leading region and determine whether it can transpose independently.

Further comparative analysis of pO26-CRL~125~ and pO111-CRL~115~ sequences showed that regions of difference were invariably associated with features that either pertain to plasmid stability and may influence host range (leading region; *traH*) or confer flexibility to the plasmid backbone (repeats -- RD1, RD2). The RD1 region, which separates the derivate Tn*21* transposon from ∆Tn*1721*, is essentially identical to the *oriV* of the IncP-1α plasmid pBS228, originally described in *Pseudomonas* \[[@B47]\]. While the *oriV*-∆Tn*1721* module is identical to one described in IncP-1β plasmid pB10 isolated from wastewater \[[@B51]\], the Tn*21*-RD1-ΔTn*1721* arrangement in pO26-CRL~125~ and pO111-CRL~115~ is unique. In both plasmids the *oriV* sequence found in Tn*21*-RD1-ΔTn*1721* is not expected to be functional as a replication feature because the *trfA* gene is missing \[[@B48]\]. Nonetheless, plasmids that carry *oriV*-type sequences are likely to gain an evolutionary advantage by virtue of the propensity of this region to serve as a hotspot for the acquisition of exogenous DNA \[[@B51],[@B71]\].

pO26-CRL~125~ and pO111-CRL~115~ are conjugative, chimeric plasmids that contain genetic signatures common to both narrow host range IncI1 family plasmids and broad host range IncP family plasmids. The distinctive features in pO26-CRL~125~ and pO111-CRL~115~, including the unique shufflon, the IncZ replicon, unique toxin/antitoxin system and unique SPATE, and the regions of difference distinguishing the two plasmids, may be representative of adaptive responses to a lifestyle where the bacteria that house these plasmids move between bovine and human gastrointestinal tracts. This existence provides an opportunity for genes to be acquired laterally from microbial populations found in the soil and in wastewater ponds generated by food animal production. Members of the well characterized IncP-1 family are frequently isolated in the environment and carry readily mobilizable antibiotic resistance modules that play an important role in the lateral transfer of accessory genes between unrelated bacteria \[[@B50],[@B72],[@B73]\]. Conjugative IncI plasmids display a narrow host range and function as vehicles for the dissemination of antimicrobial resistance determinants in pathogenic *Enterobacteriaceae* \[[@B25]\]. The sequence differences observed in pO26-CRL~125~ and pO111-CRL~115~ suggest a likely role in bacterial adaptation to rapidly changing environments or host-specific recognition \[[@B74]\].

Conclusions {#s5}
===========

This study and others \[[@B20]\] are indicative of how the problem of antibiotic resistance in humans may be linked to how antibiotics are used in food-animal production, aquaculture and horticulture. It is not possible to compartmentalize the problem because lateral gene transfer drives the movement of antibiotic resistance genes through these reservoirs and profoundly influences the delicate interplay between pathogenic and commensal bacterial populations \[[@B75]\]. Plasmids play a key role in the evolution of MDR *Enterobacteriaceae*, a key group in the struggle to curtail antibiotic resistance in the clinical environment \[[@B25]\]. Comprehensive analysis of complete sequences of plasmids carrying multiple antibiotic resistance genes is necessary to fully understand how CRL evolve and move through microbial populations in diverse settings.
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**Features of the *oriT* region of plasmids pO26-CRL~125~ and pO111-CRL~115~.** a Inc RNAI sequence of pO26-CRL~125~ and pO111-CRL~115~ compared to that of other IncI family plasmids: EHEC plasmids pO26-CRL~111~ \[[@B26]\] and pO113 \[[@B56]\], and the prototype IncI1 plasmid R64 \[S1\]. Inc RNAI is a small antisense RNA essential for control of IncI plasmids replication. Due to the trans-acting nature of this type of replication control the Inc RNAI determines also the incompatibility of IncI family members. About 70 bases in length, it is encoded downstream of the *repYZ* genes and regulates copy number by binding to a complementary mRNA sequence in the 5´ end of *repZ* and silencing *repZ* \[S2,S3\]. The four Inc RNAI sequences shown here are not identical but present conserved features (underlined) conferring the specific secondary stem-loop structure involved in target binding. IncZ plasmids are compatible with IncI1 plasmids \[S3\]. b minimum *oriT* sequence of pO26-CRL~125~ and pO111-CRL~115~ compared to that of R64. The *oriT* minimal region is located immediately upstream of *nikA* in IncI1 plasmids such as R64. It can be identified by the presence of two sets of inverted repeats (17 bp in blue, and 8 bp in red) involved in protein binding \[[@B45]\]. In pO26-CRL~125~ and pO111-CRL~115~, the *oriT* sequence was immediately adjacent to the starting codon of *nikA* and contained both sets of repeats. The 8 bp repeats are identical to those of R64 while the 17 bp differ as it may be expected since the 17 bp inverted repeats constitute part of the recognised binding site for NikA and the NikA proteins of R64 and pO26-CRL~125~ and pO111-CRL~115~ share homology but are not identical.
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**Comparison of novel SPATE sequence identified in pO26-CRL~125~ and pO111-CRL~115~ with characterized EHEC SPATEs.** The novel SPATE sequence presents all the features characteristic of SPATEs: a conserved unusually long signal sequence (in bold magenta); a functional domain (underlined), containing a peptidase S6 domain (blue highlight) with a conserved serine protease motif GDSGS (bold, underlined), where the first S is the catalytic serine (red bold); and a very well conserved β-barrel autotransporter domain (green highlight). The functional domains are specific and show low homology to the characterized EHEC EspP from O157:H7 str Sakai *E. coli* (NP_052685.1), while the autotransporter domain is identical to that of EspP. Other conserved residues involved in protease activity are shown in red bold font.
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**Open reading frames identified in the sequence of plasmids pO26-CRL~125~ and pO111-CRL~115~.**
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